November 21, 2016 / 1:12 PM / a year ago

BRIEF-Intelgenx secures a license for tadalafil erectile dysfunction dosing patent

Nov 21 (Reuters) - Intelgenx Technologies Corp :

* Intelgenx Technologies - announced signing of binding term sheet for license to Eli Lilly and co’s tadalafil dosing patent, U.S. patent no. 6,943,166

* Press release - Intelgenx secures a license for tadalafil erectile dysfunction dosing patent Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below